Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingeborg Taksdal

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2015
[A boy with a wound on his finger that would not heal]Ivar Hompland, Syed Mohammad Husain Rizvi, Mona Winge, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2003
[Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]Gunnar Saeter, Kirsten Sundby Hall, Øyvind S Bruland, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2015
[A boy with a wound on his finger that would not heal]Ivar Hompland, Syed Mohammad Husain Rizvi, Mona Winge, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2003
[Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]Gunnar Saeter, Kirsten Sundby Hall, Øyvind S Bruland, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.
Pageof 2